Back to top

Kiniksa tops Q2 estimates on Regeneron-partnered Arcalyst

Kiniksa tops Q2 estimates on Regeneron-partnered Arcalyst

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Kiniksa Pharmaceuticals International, plc (KNSA)

Regeneron Pharmaceuticals, Inc. (REGN)